Kojima et al. recently reported that treatment with CD47 antibodies attenuated atherosclerosis across multiple mouse models, consistent with their findings that CD47 is also upregulated in atherogenesis and localizes intensely to plaque necrotic core [82]. Here, CD47 is linked to atherosclerosis.